UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
(Rule 13d-101)
Under the Securities Exchange Act of 1934
(Amendment No. 7)*
|
DEVELOPERS DIVERSIFIED REALTY CORPORATION
|
(Name of Issuer)
|
Common Stock, par value $0.10 per share
|
(Title of Class of Securities)
(CUSIP Number)
|
Dennis O. Garris
Alston & Bird LLP
950 F Street, N.W.
Washington, DC 20004-1404
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this
Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
¨
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting persons initial filing on
this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise
subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13D/A
|
|
|
CUSIP No. 251591103
|
|
Page 2 of 9 Pages
|
|
|
|
|
|
|
|
(1)
|
|
Name of reporting persons
Alexander Otto
|
(2)
|
|
Check the appropriate box if a
member of a group (see instructions)
(a)
x
(b)
¨
|
(3)
|
|
SEC use only
|
(4)
|
|
Source of funds (see
instructions)
WC, PF
|
(5)
|
|
Check if disclosure of legal
proceedings is required pursuant to Items 2(d) or 2(e)
¨
|
(6)
|
|
Citizenship or place of
organization
Germany
|
Number of
shares
beneficially
owned by
each
reporting
person
with
|
|
(7)
|
|
Sole voting power
39,674,485
|
|
(8)
|
|
Shared voting power
0
|
|
(9)
|
|
Sole dispositive power
39,674,485
|
|
(10)
|
|
Shared dispositive power
0
|
(11)
|
|
Aggregate amount beneficially
owned by each reporting person
39,674,485
|
(12)
|
|
Check box if the aggregate amount
in Row (11) excludes certain shares (see instructions)
¨
|
(13)
|
|
Percent of class represented by
amount in Row (11)
14.3%*
|
(14)
|
|
Type of reporting person (see
instructions)
IN
|
*
|
= Based on 277,250,716 shares reported to be outstanding as of February 10, 2012 by the Issuer on its Form 10-K/A filed on March 26, 2012.
|
SCHEDULE 13D/A
|
|
|
CUSIP No. 251591103
|
|
Page 3 of 9 Pages
|
|
|
|
|
|
|
|
(1)
|
|
Name of reporting persons
Katharina Otto-Bernstein
|
(2)
|
|
Check the appropriate box if a
member of a group (see instructions)
(a)
x
(b)
¨
|
(3)
|
|
SEC use only
|
(4)
|
|
Source of funds (see
instructions)
WC, PF
|
(5)
|
|
Check if disclosure of legal
proceedings is required pursuant to Items 2(d) or 2(e)
¨
|
(6)
|
|
Citizenship or place of
organization
Germany
|
Number of
shares
beneficially
owned by
each
reporting
person
with
|
|
(7)
|
|
Sole voting power
15,755,505
|
|
(8)
|
|
Shared voting power
0
|
|
(9)
|
|
Sole dispositive power
15,755,505
|
|
(10)
|
|
Shared dispositive power
0
|
(11)
|
|
Aggregate amount beneficially
owned by each reporting person
15,755,505
|
(12)
|
|
Check box if the aggregate amount
in Row (11) excludes certain shares (see instructions)
¨
|
(13)
|
|
Percent of class represented by
amount in Row (11)
5.7%*
|
(14)
|
|
Type of reporting person (see
instructions)
IN
|
*
|
= Based on 277,250,716 shares reported to be outstanding as of February 10, 2012 by the Issuer on its Form 10-K/A filed on March 26, 2012.
|
SCHEDULE 13D/A
|
|
|
CUSIP No. 251591103
|
|
Page 4 of 9 Pages
|
|
|
|
|
|
|
|
(1)
|
|
Name of reporting persons
Dr. Michael Otto
|
(2)
|
|
Check the appropriate box if a
member of a group (see instructions)
(a)
x
(b)
¨
|
(3)
|
|
SEC use only
|
(4)
|
|
Source of funds (see
instructions)
WC, PF
|
(5)
|
|
Check if disclosure of legal
proceedings is required pursuant to Items 2(d) or 2(e)
¨
|
(6)
|
|
Citizenship or place of
organization
Germany
|
Number of
shares
beneficially
owned by
each
reporting
person
with
|
|
(7)
|
|
Sole voting power
2,375,916
|
|
(8)
|
|
Shared voting power
2,625,916*
|
|
(9)
|
|
Sole dispositive power
2,375,916
|
|
(10)
|
|
Shared dispositive power
2,625,916*
|
(11)
|
|
Aggregate amount beneficially
owned by each reporting person
5,001,832*
|
(12)
|
|
Check box if the aggregate amount
in Row (11) excludes certain shares (see instructions)
¨
|
(13)
|
|
Percent of class represented by
amount in Row (11)
1.8%**
|
(14)
|
|
Type of reporting person (see
instructions)
IN
|
*
|
= Includes Common Shares over which Dr. Michael Otto has power of attorney granted by Janina Vater.
|
**
|
= Based on 277,250,716 shares reported to be outstanding as of February 10, 2012 by the Issuer on its Form 10-K/A filed on March 26, 2012.
|
SCHEDULE 13D/A
|
|
|
CUSIP No. 251591103
|
|
Page 5 of 9 Pages
|
|
|
|
|
|
|
|
(1)
|
|
Name of reporting persons
Janina Otto*
|
(2)
|
|
Check the appropriate box if a
member of a group (see instructions)
(a)
x
(b)
¨
|
(3)
|
|
SEC use only
|
(4)
|
|
Source of funds (see
instructions)
WC, PF
|
(5)
|
|
Check if disclosure of legal
proceedings is required pursuant to Items 2(d) or 2(e)
¨
|
(6)
|
|
Citizenship or place of
organization
Germany
|
Number of
shares
beneficially
owned by
each
reporting
person
with
|
|
(7)
|
|
Sole voting power
0
|
|
(8)
|
|
Shared voting power
2,625,916
|
|
(9)
|
|
Sole dispositive power
0
|
|
(10)
|
|
Shared dispositive power
2,625,916
|
(11)
|
|
Aggregate amount beneficially
owned by each reporting person
2,625,916
|
(12)
|
|
Check box if the aggregate amount
in Row (11) excludes certain shares (see instructions)
¨
|
(13)
|
|
Percent of class represented by
amount in Row (11)
1.0%**
|
(14)
|
|
Type of reporting person (see
instructions)
IN
|
*
|
= In previous filings, Janina Otto was known as Janina Vater.
|
**
|
= Based on 277,250,716 shares reported to be outstanding as of February 10, 2012 by the Issuer on its Form 10-K/A filed on March 26, 2012.
|
|
|
|
CUSIP No. 251591103
|
|
Page 6 of 9 Pages
|
This Amendment No. 7 (Amendment No. 7) amends and supplements the statement on
Schedule 13D initially filed on May 15, 2009 (the Original Filing), as amended by Amendment No. 1 filed on August 20, 2009, Amendment No. 2 filed on September 14, 2009, Amendment No. 3 filed on
September 18, 2009, Amendment No. 4 filed on February 16, 2010, Amendment No. 5 filed on March 21, 2011 and Amendment No. 6 filed on April 26, 2011. Information reported in the Original Filing, as amended, remains
in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 7. Capitalized terms used and not defined in this Amendment No. 7 have the meanings set forth in the Original Filing,
as amended.
Item 4. Purpose of the Transaction
The information in Item 6 is hereby incorporated by reference.
Item 5. Interest in
Securities of the Issuer.
Item 5 is hereby amended to add the following:
(a) The Reporting Persons may be deemed to beneficially own, in the aggregate, 60,431,822 Common Shares, representing 21.8% of the Issuers
outstanding Common Shares (based on 277,250,716 shares reported to be outstanding as of February 10, 2012 by the Issuer on its Form 10-K/A filed on March 26, 2012).
(b) With respect to any rights or powers to vote, or to direct the vote of, or to dispose of, or direct the disposition of, the Common Shares referenced in paragraph 5(a), Mr. Otto has sole voting
power and sole dispositive power with regard to 39,674,485 Common Shares. Katharina Otto-Bernstein has sole voting power and sole dispositive power with regard to 15,755,505 Common Shares. Dr. Michael Otto has sole voting power and sole
dispositive power with regard to 2,375,916 Common Shares owned by him, and shared voting power and shared dispositive power with regard to 2,625,916 Common Shares owned by his daughter Janina Otto pursuant to a power of attorney. Janina Otto has
shared voting power and shared dispositive power with regard to 2,625,916 Common Shares.
(c) The Reporting Persons have not effected any
transactions in the Common Shares in the past 60 days.
|
|
|
CUSIP No. 251591103
|
|
Page 7 of 9 Pages
|
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
Item 6 is hereby amended to add the following:
On March 29, 2012, Mr. Alexander Otto (Mr. Otto) entered into a covered call option agreement (Covered Call
Agreement). Pursuant to the Covered Call Agreement, Mr. Otto wrote a covered call option with respect to 6,810,538 shares beneficially owned by Mr. Otto, which had an aggregate market value of $100,523,540.88. The covered call option
is separated into 15 separate components containing an aggregate amount of 6,810,538 call options: 14 of which contain 454,035 call options and 1 of which contains 454,048 call options. All of the call options under the Covered Call Agreement have
an exercise price of $15.0527 per share, which was determined on March 30, 2012. Each of the 14 components containing 454,035 call options expires on October 8, 9, 10, 11, 12, 15, 16, 17, 18, 19, 22, 23, 24 and 25 of 2012, respectively,
and the component containing 454,048 call options expires on October 26, 2012 (for each component, the Expiration Date). The call options constituting each component of the covered call option may be exercised only on the Expiration
Date for that component. The underlying shares with respect to the options are pledged by Mr. Otto until such time as the options expire.
Item 7. Material to Be Filed as Exhibits.
Exhibit 1
|
Joint Filing Agreement, dated May 15, 2009, among Mr. Otto, Katharina Otto-Bernstein, Dr. Michael Otto and Janina Vater
|
Exhibit 2
|
Covered Call Agreement dated March 29, 2012 between Deutsche Bank AG and Alexander Otto
|
|
|
|
CUSIP No. 251591103
|
|
Page 8 of 9 Pages
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: April 4, 2012
|
|
|
/s/ KG CURA Vermögensverwaltung G.m.b.H. & Co., by power of attorney
|
|
|
By:
|
|
Dr. Thomas Finne
|
For:
|
|
Alexander Otto
|
|
/s/ KG CURA Vermögensverwaltung G.m.b.H. & Co., by power of attorney
|
|
|
By:
|
|
Dr. Thomas Finne
|
For:
|
|
Katharina Otto-Bernstein
|
|
/s/ KG CURA Vermögensverwaltung G.m.b.H. & Co., by power of attorney
|
|
|
By:
|
|
Dr. Thomas Finne
|
For:
|
|
Dr. Michael Otto
|
|
/s/ KG CURA Vermögensverwaltung G.m.b.H. & Co., by power of attorney
|
|
|
By:
|
|
Dr. Thomas Finne
|
For:
|
|
Janina Otto
|
|
|
|
CUSIP No. 251591103
|
|
Page 9 of 9 Pages
|
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Exhibit Description
|
1
|
|
Joint Filing Agreement, dated May 15, 2009, among Mr. Otto, Katharina Otto-Bernstein, Dr. Michael Otto and Janina Vater
|
|
|
2
|
|
Covered Call Agreement dated March 29, 2012 between Deutsche Bank AG and Alexander Otto
|
Developers Realty (NYSE:DDR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Developers Realty (NYSE:DDR)
Historical Stock Chart
From Jul 2023 to Jul 2024